Traws Pharma (TRAW) Cash Flow: Operating & Free Cash Flow

Traws Pharma Cash Flow Statement Analysis

Values in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Cash flow statement showing operating, investing, and financing activities for Traws Pharma, Inc. (TRAW) - Annual data in millions USD
Breakdown	FY 2025	FY 2024	FY 2023	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period ending	Dec 2025	Dec 2024	Mar 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018	Dec 2017
Operating Activities
Net Income	9.17	-166.52	-18.95	-18.95	-18.96	-16.16	-25.16	-21.50	-20.57	-24.09
Depreciation & Amortization	0.06	0.01	0.02	0.02	0.01	0.01	0.01	0.01	0.06	0.09
Stock Based Compensation	0.73	1.39	1.30	1.30	1.17	0.58	0.37	0.00	0.00	0.00
Change in Working Capital	-2.03	-6.57	-0.30	-0.30	1.48	-3.59	1.49	-0.33	-1.07	0.10
Change in Accounts Receivable	-2.03	-1.75	0.01	0.01	0.00	0.01	0.06	-0.06	0.02	-0.03
Change in Accounts Payable	-0.61	0.65	1.76	1.76	1.10	-2.08	0.56	0.23	-1.45	0.86
Change in Other Working Capital	0.61	-5.47	-2.07	-1.26	0.38	-1.53	1.10	-0.50	0.36	-0.73
Other Operating Activities	-26.12	141.90	1.30	-	1.17	-0.32	0.21	0.99	-1.11	0.08
Net Cash from Operating Activities	-18.19	-29.79	-17.93	-17.93	-16.29	-19.49	-23.08	-20.83	-22.70	-23.82
Investing Activities
Capital Expenditures	-2.59	0.00	-0.01	-0.01	0.00	0.00	-0.02	-0.06	0.00	0.00
Acquisitions	0.00	-3.65	0.00	-	0.00	0.00	0.00	0.00	0.00	0.00
Net Cash from Investing Activities	-2.59	-3.65	-0.01	-0.01	0.00	0.00	-0.02	-0.06	0.00	0.00
Financing Activities
Common Stock Issued	5.61	33.98	0.00	-	0.00	55.04	19.36	21.76	35.07	6.36
Common Stock Repurchased	-2.40	0.00	0.00	-	0.00	0.00	0.00	0.00	0.00	0.00
Other Financing Activities	0.00	0.00	0.00	-	0.00	0.52	10.30	4.89	0.59	0.00
Net Cash from Financing Activities	3.20	33.98	0.00	-	0.00	55.56	19.36	26.65	35.66	6.36
Summary
Effect of Forex Changes on Cash	0.05	-0.02	0.01	0.01	-0.02	-0.03	0.03	-0.01	-0.02	0.03
Net Change in Cash	-17.52	0.52	-17.94	-17.94	-16.31	36.07	-3.70	5.76	12.95	-17.43
Cash at Beginning of Period	21.34	20.82	38.76	38.76	55.07	19.03	22.73	16.97	4.02	21.45
Cash at End of Period	3.82	21.34	20.82	20.82	38.76	55.07	19.03	22.73	16.97	4.02
Free Cash Flow	-20.77	-29.79	-17.95	-17.95	-16.29	-19.49	-23.09	-20.89	-22.70	-23.82

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Traws Pharma Cash Flow

What is Traws Pharma's free cash flow?

Traws Pharma had negative free cash flow of $20.77M in fiscal 2025 (fiscal year ended Dec 31, 2025), operating cash flow of −$18.18M minus $2.58M of capital expenditures.

How much does Traws Pharma spend on capital expenditures?

Traws Pharma spent $2.58M on capital expenditures in fiscal 2025.

Does Traws Pharma pay dividends or buy back shares?

Yes. In fiscal 2025 Traws Pharma returned $2.40M in share buybacks to shareholders, according to its cash flow statement.

What is free cash flow?

Free cash flow is operating cash flow minus capital expenditures. It is the cash a company has left for dividends, buybacks, debt repayment or acquisitions after funding its operations and investment. Full definition